Elaine Mardis Selected Research

Elaine Mardis Research Topics

9	Neoplasms (Cancer) 05/2022 - 09/2004
6	Breast Neoplasms (Breast Cancer) 11/2017 - 08/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 09/2014
2	Pathologic Complete Response 11/2017 - 03/2009
1	Diarrhea 04/2016
1	Exanthema (Rash) 04/2016
1	Fatigue 04/2016
1	Body Weight (Weight, Body) 09/2015
1	Neoplasm Metastasis (Metastasis) 03/2015
1	Mouth Neoplasms (Oral Cancer) 03/2015
1	Squamous Cell Carcinoma of Head and Neck 03/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Leukemia 09/2014
1	Philadelphia Chromosome 09/2014
1	Adenocarcinoma 09/2004
1	Lung Neoplasms (Lung Cancer) 09/2004

4	Estrogen ReceptorsIBA 11/2017 - 03/2009
2	Estrogens (Estrogen)FDA Link 11/2017 - 08/2007
2	Pharmaceutical PreparationsIBA 11/2017 - 09/2015
2	Phosphotransferases (Kinase)IBA 09/2014 - 09/2004
2	Phenobarbital (Luminal)FDA Link 03/2009 - 08/2007
1	AntigensIBA 10/2021
1	Ephrin-A2 (Ephrin A2)IBA 10/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2021
1	Ikaros Transcription FactorIBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 11/2017
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2017
1	MK 2206IBA 11/2017
1	Goserelin (Zoladex)FDA Link 11/2017
1	NVP-BKM120IBA 04/2016
1	Fulvestrant (Faslodex)FDA Link 04/2016
1	Transaminases (Aminotransferases)IBA 04/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2015
1	CarcinogensIBA 03/2015
1	NucleotidesIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	MA 12 (MA12)IBA 08/2012
1	Tamoxifen FDA LinkGeneric 08/2012
1	taxaneIBA 03/2009
1	P-2 (P 2)IBA 03/2009
1	AnthracyclinesIBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 12/2008
1	DNA (Deoxyribonucleic Acid)IBA 08/2007
1	ErbB Receptors (EGF Receptor)IBA 09/2004
1	Gefitinib (Iressa)FDA Link 09/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2004
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2004